CAAS Capital Management’s Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HZON.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-66,666
Closed -$62K 1028
2021
Q4
$62K Hold
66,666
﹤0.01% 743
2021
Q3
$60K Buy
+66,666
New +$71.2K ﹤0.01% 811

Other funds holding HZON.WS

CAAS Capital Management's HZON.WS Position: Q1 2022 in Review

CAAS Capital Management sold out of Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HZON.WS) in Q1 2022, closing a stake of 66,666 shares — an estimated $62K sold.

CAAS Capital Management first reported a position in HZON.WS in Q3 2021 and held it in 2 quarters. The position peaked at $62K in Q4 2021. 35 funds tracked by Wall St. Rank hold HZON.WS as of Q1 2022.

  • CAAS Capital Management reported no remaining Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 66,666 Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $62K.
  • CAAS Capital Management first reported a position in Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • CAAS Capital Management's Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $62K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.